Search

Displaying results 9911 - 9920 of 10000 in total
  1. Drug

    Theodrenaline

    go.drugbank.com/drugs/DB12927
    Investigational

    Theodrenaline is under investigation in clinical trial NCT01311414 (Effect of Cafedrine/Theodrenaline and Urapidil on Cerebral Oxygenation).

  2. Drug

    Ezurpimtrostat

    go.drugbank.com/drugs/DB16458
    Investigational

  3. Drug

    BMS-919373

    go.drugbank.com/drugs/DB15047
    Investigational

    BMS-919373 is under investigation in clinical trial NCT02153437 (Study of the Effects of BMS-919373 on the Electrical Activity of the Heart Using Pacemakers).

  4. Drug

    Vanillic acid

    go.drugbank.com/drugs/DB02130
    Experimental

    It is the intermediate product in the two-step bioconversion of ferulic acid to vanillin. (J Biotechnol 1996;50(2-3):107-13).

  5. Drug

    MYR-101

    go.drugbank.com/drugs/DB17075
    Investigational

    Canavan disease is a fatal childhood genetic disorder characterized by white matter degeneration in the brain. … ASPA is produced in oligodendrocytes, and participates in the metabolism of N-acetylaspartate (NAA).

  6. Drug

    Mitazalimab

    go.drugbank.com/drugs/DB15225
    Investigational

    Mitazalimab is under investigation in clinical trial NCT02379741 (ADC-1013 First-in-Human Study).

  7. Drug

    Methcathinone

    go.drugbank.com/drugs/DB15339
    Experimental

    Methcathinone is under investigation in clinical trial NCT02617862 (PCI Imaging System in Pediatric Ophthalmology).

  8. Drug

    SER-100

    go.drugbank.com/drugs/DB16013
    Investigational

    SER-100 is under investigation in clinical trial NCT01987284 (SER100 in Isolated Systolic Hypertension).

  9. Drug

    RD06-04

    go.drugbank.com/drugs/DB24647
    Investigational

    RD06-04 is under investigation in clinical trial NCT06986018 (Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV). … RD06-04 is a biologic drug.

  10. Drug

    Sitravatinib

    go.drugbank.com/drugs/DB15036
    Investigational

    Sitravatinib is under investigation in clinical trial NCT03680521 (Neoadjuvant Sitravatinib in Combination With Nivolumab in Patients With Clear Cell Renal Cell Carcinoma).